规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | PLK1 ↓ ↑ | PLK2 ↓ ↑ | PLK3 ↓ ↑ | PLK4 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HMN-214 | ✔ | 99%+ | |||||||||||||||||
SBE13 HCl |
++++
PLK1, IC50: 200 pM |
98% | |||||||||||||||||
Onvansertib |
+++
PLK1, IC50: 2 nM |
99%+ | |||||||||||||||||
Volasertib |
++++
PLK1, IC50: 0.87 nM |
97% | |||||||||||||||||
GSK461364 |
+++
PLK1, Ki: 2.2 nM |
99%+ | |||||||||||||||||
MLN0905 |
+++
PLK1, IC50: 2 nM |
99%+ | |||||||||||||||||
Ro3280 |
++
PLK1, IC50: 3 nM |
99% | |||||||||||||||||
(E/Z)-Rigosertib sodium |
+
PLK1, IC50: 9 nM |
+
PLK2, IC50: 260 nM |
Bcr-Abl | 99%+ | |||||||||||||||
BI 2536 |
++++
PLK1, IC50: 0.83 nM |
++
PLK2, IC50: 3.5 nM |
+
PLK3, IC50: 9.0 nM |
99%+ | |||||||||||||||
CFI-400945 |
++
PLK4, IC50: 2.8 nM |
Tie-2 | 98% | ||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Centrinone (LCR-263) is a selective and reversible inhibitor of polo-like kinase 4 (PLK4) with a Ki of 0.16 nM[1]. |
体外研究 | Centrinone (LCR-263) shows significant specificity, being over 1000 times more selective for Polo-like kinase 4 (Plk4) than for Aurora kinases A/B, and does not impact the phosphorylation of Aurora A or B substrates at doses that cause centrosome depletion. When administered to HeLa human cervical carcinoma cells, Centrinone (LCR-263) initiates a gradual decrease in the presence of centriolar and pericentriolar material markers with each cell division cycle, leading to most cells eventually lacking centrioles and centrosomes. This effect suggests Plk4's role in centriole duplication extends to differentiated cells, as seen in the reduced number of centrioles in multiciliated Xenopus epithelial cells. Centrinone (LCR-263) treatment results in the depletion of centrosomes across various vertebrate cell lines. The absence of centrosomes causes normal cells to enter an irreversible, senescence-like state during the G1 phase through a p53-dependent mechanism, which is notable for its independence from DNA damage, stress, Hippo pathway signaling, extended mitosis, or errors in chromosome segregation[1]. |
Concentration | Treated Time | Description | References | |
NIH/3T3 mouse embryonic fibroblasts | 100 nM | depleted centrosomes | Science. 2015 Jun 5;348(6239):1155-60 | |
A375 cells | 200 nM | 4 days | Induced centrosome overduplication | Elife. 2022 Jun 27;11:e73944 |
RPE-1 cells | 500 nM | 4 days | Resulted in cells containing either a single or no centrosome | Elife. 2022 Jun 27;11:e73944 |
HCT116 cells | 100 nM | 4 days | Observed the dynamic properties of NuMA in acentrosomal spindle poles, finding that NuMA is more static in acentrosomal spindle poles. | EMBO J. 2020 Jan 15;39(2):e102378 |
HeLa cells | 100 nM | 3-5 days | Induced the formation of acentrosomal spindles to study the mechanism of spindle bipolarity establishment in human somatic cells without centrosomes. | EMBO J. 2020 Jan 15;39(2):e102378 |
HeLa cells | 125 nM | at least 4 days | Depletion of centrosomes by inhibiting Plk4 activity to verify the effect of Centrinone on centrosome depletion | Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):E6590-E6599 |
hTERT-RPE1 immortalized retinal pigment epithelial cells (RPE1 cells) | 150 nM | 5 days | To analyze the effect of centrosome removal in normal and cancer cells, centrinone treatment was found to block centriole duplication, leading to p53-dependent G1 arrest | J Cell Biol. 2016 Jul 18;214(2):155-66 |
RPE-1 cells | 200 nM | 4 days | Induced centrosome overduplication, resulting in approximately 50% of cells with supernumerary centrosomes | Elife. 2022 Jun 27;11:e73944 |
8305c cells | 0, 2, 4, 8, 16, 32 and 64 nM | 72 h | Centrinone decreased cell viability, induced cell apoptosis, arrested cell cycle at G2/M phase and inactivated Wnt/β-catenin signaling in a dose-dependent manner. | Cancer Biol Ther. 2023 Dec 31;24(1):2223383 |
C643 cells | 0, 2.5, 5, 10, 20, 40 and 80 nM | 72 h | Centrinone decreased cell viability, induced cell apoptosis, arrested cell cycle at G2/M phase and inactivated Wnt/β-catenin signaling in a dose-dependent manner. | Cancer Biol Ther. 2023 Dec 31;24(1):2223383 |
HeLa cells | 100 nM Centrinone | 20 h | Inhibition of Plk4 kinase activity induced irregular, non-spherical assemblies of GFP-Plk4 | Nat Commun. 2019 Apr 18;10(1):1810 |
HeLa human cervical carcinoma cells | 100 nM | 7 days | led to a progressive reduction in foci containing centriolar and pericentriolar material markers at each round of cell division, until most cells lacked centrioles and centrosomes | Science. 2015 Jun 5;348(6239):1155-60 |
CHP134 neuroblastoma cells | 150 nM | 3 cell cycles | To assess the effect of TRIM37 levels on sensitivity to PLK4 inhibition. CHP134 cells with high TRIM37 expression ceased proliferation following centrinone treatment, suggesting synthetic lethality with PLK4 inhibition. | Nature. 2020 Sep;585(7825):440-446 |
RPE1 cells | 150 nM | 3 cell cycles | To assess the effect of PLK4 inhibition on mitosis. Following centrinone treatment, chromosome segregation fails in ~10% of cells, leading to eventual growth arrest. | Nature. 2020 Sep;585(7825):440-446 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.58mL 0.32mL 0.16mL |
7.89mL 1.58mL 0.79mL |
15.78mL 3.16mL 1.58mL |
CAS号 | 1798871-30-3 |
分子式 | C26H25F2N7O6S2 |
分子量 | 633.65 |
SMILES Code | CC1=CC(NC2=NC(SC3=CC=C(S(=O)(CC4=CC=CC([N+]([O-])=O)=C4F)=O)C=C3F)=NC(N5CCOCC5)=C2OC)=NN1 |
MDL No. | MFCD28969654 |
别名 | LCR-263 |
运输 | 蓝冰 |
InChI Key | HHJSKDRCUMVWKF-UHFFFAOYSA-N |
Pubchem ID | 91801159 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
溶解方案 |
DMSO: 30 mg/mL(47.34 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|